CAS: 2086772-26-9
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | JNJ-64619178 REF: TM-T15624CAS: 2086772-26-9 | 98.44% - 99.63% | 88.00 €~1,638.00 € | Mon 02 Dec 24 |
 | JNJ-64619178 REF: 3D-LID77226CAS: 2086772-26-9 | Min. 95% | To inquire | Tue 21 Jan 25 |
JNJ-64619178
CAS:2086772-26-9
JNJ-64619178: selective, oral, pseudo-irreversible PRMT5 inhibitor (IC50: 0.14 nM), effective in lung cancer.
Formula:
C22H23BrN6O2
Purity:
98.44% - 99.63%
Color and Shape:
Solid
Molecular weight:
483.36
Ref: TM-T15624
| 1mg | 88.00 € | ||
| 5mg | 168.00 € | ||
| 10mg | 271.00 € | ||
| 25mg | 560.00 € | ||
| 50mg | 932.00 € | ||
| 100mg | 1,638.00 € | ||
| 1mL*10mM (DMSO) | 182.00 € |
Estimated delivery in United States, on Monday 2 Dec 2024
JNJ-64619178
CAS:2086772-26-9
JNJ-64619178 is a novel small molecule that targets the methyltransferase domain of the protein PRMT5. …
Formula:
C22H23BrN6O2
Purity:
Min. 95%
Molecular weight:
483.36 g/mol
Ref: 3D-LID77226
| 1mg | 248.00 € | ||
| 2mg | 364.00 € | ||
| 5mg | 517.00 € | ||
| 10mg | 740.00 € | ||
| 25mg | 1,102.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
